Tom H. Karlsen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tom H. Karlsen has a total of 98 co-authors. Here are the top co-authors by number of shared publications:
Erik Schrumpf
Norwegian PSC Research Center, Clinic for Specialized Medicine and Surgery, Oslo University Hospital, Rikshospitalet, 0027 Oslo, Norway
6 shared publications- Andre Franke
Institute of Clinical Molecular Biology, Kiel University and University Hospital Schleswig-Holstein, Kiel, Germany
4 shared publications Benedicte A. Lie
Institute of Immunology, Rikshospitalet University Hospital, Oslo, Norway
4 shared publicationsKirsten Muri Boberg
Norwegian PSC Research Center, Clinic for Specialized Medicine and Surgery, Oslo University Hospital, Rikshospitalet, 0027 Oslo, Norway
4 shared publications- Severine Vermeire
Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium
4 shared publications Annika Bergquist
Department of Gastroenterology and Hepatology, Karolinska University Hospital Huddinge, Stockholm, Sweden
3 shared publications
Latest Publications
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Novel Susceptibility Loci for Primary Sclerosing Cholangitis Identified by Genome-Wide Association and Replication Analysis
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Novel Susceptibility Loci for Primary Sclerosing Cholangitis Identified by Genome-Wide Association and Replication Analysis
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Three Genetic Susceptibility Loci Indicate a Role for IL2, REL and CARD9 in Primary Sclerosing Cholangitis
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Three Genetic Susceptibility Loci Indicate a Role for IL2, REL and CARD9 in Primary Sclerosing Cholangitis
- Open Access
- 17 December 2010
- Published by Springer Nature in BMC Bioinformatics
- Vol. 11 (1) , 600
SNPexp - A web tool for calculating and visualizing correlation between HapMap genotypes and gene expression levels
Background: Expression levels for 47294 transcripts in lymphoblastoid cell lines from all 270 HapMap phase II individuals, and genotypes (both HapMap phase II and III) of 3.96 million single nucleotide polymorphisms (SNPs) in the same individuals are publicly available. We aimed to generate a user-friendly web based tool for visualization of the correlation between SNP genotypes within a specified genomic region and a gene of interest, which is also well-known as an expression quantitative trait locus (eQTL) analysis. Results: SNPexp is implemented as a server-side script, and publicly available on this website: http://tinyurl.com/snpexp. Correlation between genotype and transcript expression levels are calculated by performing linear regression and the Wald test as implemented in PLINK and visualized using the UCSC Genome Browser. Validation of SNPexp using previously published eQTLs yielded comparable results. Conclusions: SNPexp provides a convenient and platform-independent way to calculate and visualize the correlation between HapMap genotypes within a specified genetic region anywhere in the genome and gene expression levels. This allows for investigation of both cis and trans effects. The web interface and utilization of publicly available and widely used software resources makes it an attractive supplement to more advanced bioinformatic tools. For the advanced user the program can be used on a local computer on custom datasets.
- 17 December 2010
- Published by Springer Nature in BMC Bioinformatics
- Vol. 11 (1) , 600
Open AccessSNPexp - A web tool for calculating and visualizing correlation between HapMap genotypes and gene expression levels
Background: Expression levels for 47294 transcripts in lymphoblastoid cell lines from all 270 HapMap phase II individuals, and genotypes (both HapMap phase II and III) of 3.96 million single nucleotide polymorphisms (SNPs) in the same individuals are publicly available. We aimed to generate a user-friendly web based tool for visualization of the correlation between SNP genotypes within a specified genomic region and a gene of interest, which is also well-known as an expression quantitative trait locus (eQTL) analysis. Results: SNPexp is implemented as a server-side script, and publicly available on this website: http://tinyurl.com/snpexp. Correlation between genotype and transcript expression levels are calculated by performing linear regression and the Wald test as implemented in PLINK and visualized using the UCSC Genome Browser. Validation of SNPexp using previously published eQTLs yielded comparable results. Conclusions: SNPexp provides a convenient and platform-independent way to calculate and visualize the correlation between HapMap genotypes within a specified genetic region anywhere in the genome and gene expression levels. This allows for investigation of both cis and trans effects. The web interface and utilization of publicly available and widely used software resources makes it an attractive supplement to more advanced bioinformatic tools. For the advanced user the program can be used on a local computer on custom datasets.
- 1 October 2010
- Published by Elsevier in Best Practice & Research Clinical Gastroenterology
- Vol. 24 (5) , 655-666
Primary sclerosing cholangitis
- 1 October 2010
- Published by Elsevier in Best Practice & Research Clinical Gastroenterology
- Vol. 24 (5) , 655-666
Primary sclerosing cholangitis
- 31 May 2010
- Published by Elsevier in Gastroenterology
- Vol. 138 (5) , -677-677
W1219 Genome-Wide Association Study for Ulcerative Colitis Demonstrates Novel Associations at Chromosome 22 and 7
- 31 May 2010
- Published by Elsevier in Gastroenterology
- Vol. 138 (5) , -677-677
W1219 Genome-Wide Association Study for Ulcerative Colitis Demonstrates Novel Associations at Chromosome 22 and 7
- 1 May 2010
- Published by Wolters Kluwer Health in Current Opinion in Gastroenterology
- Vol. 26 (3) , 251-258
Genetics of cholestatic liver disease in 2010
Many of the cholestatic diseases show similar clinical features, despite underlying differences in the genetic etiology. The present review aims to present recent insight into this etiological heterogeneity. Mutations in the genes causing progressive familial intrahepatic cholestasis are also involved in less severe phenotypes like benign recurrent intrahepatic cholestasis, gallstone disease, intrahepatic cholestasis of pregnancy and drug-induced cholestasis. This probably represents a continuum of severity of the mutations involved, but also complex patterns of inheritance ranging from monogenic autosomal recessive disorders to heterozygosity only conferring a moderate increase in disease risk, where additional genetic or environmental factors are needed to acquire a disease phenotype. Recent genome-wide association studies in the inflammatory cholestatic diseases primary biliary cirrhosis and primary sclerosing cholangitis have revealed susceptibility genes involved in autoimmunity and inflammatory bowel disease, whereas the genetic risk factors for the biliary preference of these diseases remain unknown. The complexity of the genetic contribution to cholestatic liver disease needs to be accounted for to fully understand the pathogenesis of these conditions.
- 1 May 2010
- Published by Wolters Kluwer Health in Current Opinion in Gastroenterology
- Vol. 26 (3) , 251-258
Genetics of cholestatic liver disease in 2010
Many of the cholestatic diseases show similar clinical features, despite underlying differences in the genetic etiology. The present review aims to present recent insight into this etiological heterogeneity. Mutations in the genes causing progressive familial intrahepatic cholestasis are also involved in less severe phenotypes like benign recurrent intrahepatic cholestasis, gallstone disease, intrahepatic cholestasis of pregnancy and drug-induced cholestasis. This probably represents a continuum of severity of the mutations involved, but also complex patterns of inheritance ranging from monogenic autosomal recessive disorders to heterozygosity only conferring a moderate increase in disease risk, where additional genetic or environmental factors are needed to acquire a disease phenotype. Recent genome-wide association studies in the inflammatory cholestatic diseases primary biliary cirrhosis and primary sclerosing cholangitis have revealed susceptibility genes involved in autoimmunity and inflammatory bowel disease, whereas the genetic risk factors for the biliary preference of these diseases remain unknown. The complexity of the genetic contribution to cholestatic liver disease needs to be accounted for to fully understand the pathogenesis of these conditions.
- 1 May 2010
- Published by Wolters Kluwer Health in Hepatology
- Vol. 51 (5) , 1833-1842
the Utility of Genome-Wide Association Studies in Hepatology
Over the last 4 years, more than 450 genome-wide association studies (GWAS) have been successfully performed in a variety of human traits, of which approximately 2% relates to the field of hepatology. Whereas the many robust susceptibility gene findings have provided insight into fundamental physiological aspects of the phenotypes that have been studied, the widespread application has also revealed important limitations of the GWAS design. This review aims to systematically summarize both the strengths and the weaknesses of GWAS, as well as underscore important experiences made in model diseases outside the field of hepatology. By reviewing the GWAS performed in hepatology so far on this broader background, extensions and guidelines for the rational application of the study design in hepatology are proposed. (Hepatology 2010)
- 1 May 2010
- Published by Wolters Kluwer Health in Hepatology
- Vol. 51 (5) , 1833-1842
the Utility of Genome-Wide Association Studies in Hepatology
Over the last 4 years, more than 450 genome-wide association studies (GWAS) have been successfully performed in a variety of human traits, of which approximately 2% relates to the field of hepatology. Whereas the many robust susceptibility gene findings have provided insight into fundamental physiological aspects of the phenotypes that have been studied, the widespread application has also revealed important limitations of the GWAS design. This review aims to systematically summarize both the strengths and the weaknesses of GWAS, as well as underscore important experiences made in model diseases outside the field of hepatology. By reviewing the GWAS performed in hepatology so far on this broader background, extensions and guidelines for the rational application of the study design in hepatology are proposed. (Hepatology 2010)
- 1 March 2010
- Published by Elsevier in Gastroenterology
- Vol. 138 (3) , 1102-1111
Genome-Wide Association Analysis in Primary Sclerosing Cholangitis
- 1 March 2010
- Published by Elsevier in Gastroenterology
- Vol. 138 (3) , 1102-1111
Genome-Wide Association Analysis in Primary Sclerosing Cholangitis
- 1 June 2009
- Published by Elsevier in Journal of Hepatology
- Vol. 50 (6) , 1278-1280
Genome-wide association studies reach hepatology
- 1 June 2009
- Published by Elsevier in Journal of Hepatology
- Vol. 50 (6) , 1278-1280
Genome-wide association studies reach hepatology
- Open Access
- 1 January 2008
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 14 (24) , 3781-3791
Autoantibodies in primary sclerosing cholangitis
Autoantibodies in primary sclerosing cholangitis
- 1 January 2008
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 14 (24) , 3781-3791
Open AccessAutoantibodies in primary sclerosing cholangitis
Autoantibodies in primary sclerosing cholangitis